High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 475-483

  Wassenaar, M J E ^a   Biermasz, N R ^a   Hamdy, N A T ^a   Zillikens, M C ^b   Van Meurs, J B J ^b   Rivadeneira, F ^b   Hofman, A ^b   Uitterlinden, A G ^b   Stokkel, M P M ^a   Roelfsema, F ^a   Kloppenburg, M ^a   Kroon, H M ^a   Romijn, J A ^a   Pereira, A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; HYDROCORTISONE; PROCOLLAGEN C PROTEINASE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TESTOSTERONE; VITAMIN D;

ACROMEGALY; ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGONADISM; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RADIOTHERAPY; REMISSION; RISK FACTOR; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION; CASE CONTROL STUDY; DISEASE CONTROL; RISK ASSESSMENT;

ACROMEGALY; AGED; BONE DENSITY; FEMALE; HUMANS; MALE; MIDDLE AGED; SPINAL FRACTURES;

EID: 79953202535     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1005     Document Type: Article

References (39)

1. Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V & Scillitani A. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clinical Endocrinology 2008 70 378-382. (doi:10.1111/j.1365-2265.2008.03322.x)
2. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA & Roelfsema F. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. European Journal of Endocrinology 2005 152 53-60. (doi:10.1530/eje.1.01820)
3. Bolanowski M, Daroszewski J, Medras M & Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. Journal of Bone and Mineral Metabolism 2006 24 72-78. (doi:10.1007/s00774-005-0649-9)
4. Lesse GP, Fraser WD, Farquharson R, Hipkin L & Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clinical Endocrinology 1998 48 59-65. (doi:10.1046/j.1365-2265.1998.00349.x)
5. Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V & Liuzzi A. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clinical Endocrinology 2003 58 725-731. (doi:10.1046/j.1365-2265.2003.01777.x)
6. Aloia JF, Petrak Z, Ellis K & Cohn SH. Body composition and skeletal metabolism following pituitary irradiation in acromegaly. American Journal of Medicine 1976 61 59-63. (doi:10.1016/0002-9343(76)90041-3)
7. Halse J, Melsen F & Mosekilde L. Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinologica 1981 97 18-22. (doi:10.1530/acta.0.0970018)
8. Ezzat S, Melmed S, Endres D, Eyre DR & Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. Journal of Clinical Endocrinology and Metabolism 1993 76 1452-1457. (doi:10.1210/jc.76.6.1452)
9. Ho PJ, Fig LM, Barkan AL & Shapiro B. Bone mineral density of the axial skeleton in acromegaly. Journal of Nuclear Medicine 1992 33 1608-1612.
10. Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H & Chihara K. Bone metabolism and body composition in Japanese patients with active acromegaly. Clinical Endocrinology 2001 55 175-181. (doi:10.1046/j.1365-2265. 2001.01280.x)
11. Diamond T, Nery L & Posen S. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Annals of Internal Medicine 1989 111 567-573. (Pubitemid 19244557)
12. Kayath MJ & Vieira JG. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporosis International 1997 7 226-230. (doi:10.1007/BF01622293)
13. Zgliczynski W, Kochman M, Misiorowski W & Zdunowski P. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender. Neuro Endocrinology Letters 2007 28 621-628.
14. Vestergaard P & Mosekilde L. Fracture risk is decreased in acromegaly - a potential beneficial effect of growth hormone. Osteoporosis International 2004 15 155-159. (doi:10.1007/s00198-003-1531-z)
15. Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L & Giustina A. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. Journal of Bone and Mineral Research 2005 20 1837-1844. (doi:10.1359/JBMR.050603)
16. Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L & Giustina A. Prevalence of vertebral fractures is men with acromegaly. Journal of Clinical Endocrinology and Metabolism 2008 93 4649-4655. (doi:10.1210/jc.2008-0791)
17. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA & Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. Journal of Clinical Endocrinology and Metabolism 2004 89 2789-2796. (doi:10.1210/jc.2003-032041)
18. Biermasz NR, Pereira AM, Smit JW, Romijn JA & Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. Journal of Clinical Endocrinology and Metabolism 2005 90 2731-2739. (doi:10.1210/jc.2004-2297)
19. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA & Roelfsema F. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 2004 89 5369-5376. (doi:10.1210/jc.2004-0669)
20. Janssen YJ, Frolich M & Roelfsema F. A low starting dose of genotropin in growth hormone-deficient adults. Journal of Clinical Endocrinology and Metabolism 1997 82 129-135. (doi:10.1210/jc.82.1.129)
21. Cole TJ. The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition 1990 44 45-60. (Pubitemid 20177198)
22. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G & Wit JM. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Hormone Research 1998 50 166-176. (doi:10.1159/000023268)
23. Genant HK, Wu CY, van Kuijk C & Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research 1993 8 1137-1148. (doi:10.1002/jbmr.5650080915)
24. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S & Kanis JA. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporosis International 1993 3 138-147. (doi:10.1007/BF01623275)
25. Van der Klift M, De Laet CE, McCloskey EV, Hofman A & Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. Journal of Bone and Mineral Research 2002 17 1051-1056. (doi:10.1359/jbmr.2002.17.6. 1051)
26. Wassenaar MJ, Biermasz NR, van Duinen N, van der Klaauw AA, Pereira AM, Roelfsema F, Smit JW, Kroon HM, Kloppenburg M & Romijn JA. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. European Journal of Endocrinology 2009 160 357-365. (doi:10.1530/EJE-08- 0845)
27. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT & Orwoll ES. Hip fracture in women without osteoporosis. Journal of Clinical Endocrinology and Metabolism 2005 90 2787-2793. (doi:10.1210/jc.2004-1568)
28. Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J & Silman AJ. Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporosis International 2000 11 248-254. (doi:10.1007/ s001980050288)
29. Ismail AA, O'Neill TW, Cooper C & Silman AJ. Risk factors for vertebral deformities in men: relationship to number of vertebral deformities. European Vertebral Osteoporosis Study Group. Journal of Bone and Mineral Research 2000 15 278-283. (doi:10.1359/jbmr.2000.15.2.278)
30. Silman AJ, O'Neill TW, Cooper C, Kanis J & Felsenberg D. Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. Journal of Bone and Mineral Research 1997 12 813-819. (doi:10.1359/jbmr.1997.12.5.813)
31. Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch JA, Masaryk P, Pols HA, Poor G, Reid DM, Scheidt-Nave C, Weber K, Varlow J, Kanis JA, O'Neill TW& Silman AJ. Bone density variation and its effects on risk of vertebral deformity in men andwomen studied in thirteen European centers: the EVOS Study. Journal of Bone and Mineral Research 1997 12 1883-1894. (doi:10.1359/jbmr.1997.12.11.1883)
32. Ferrar L, Jiang G, Cawthon PM, San VR, Fullman R, Lambert L, Cummings SR, Black DM, Orwoll E, Barrett-Connor E, Ensrud K, Fink HA & Eastell R. Identification of vertebral fracture and nonosteoporotic short vertebral height in men: the MrOS Study. Journal of Bone and Mineral Research 2007 22 1434-1441. (doi:10.1359/jbmr.070608)
33. Johnell O & Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006 17 1726-1733. (doi:10.1007/s00198-006-0172-4)
34. Ross PD, Davis JW, Epstein RS & Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Annals of Internal Medicine 1991 114 919-923.
35. Ross PD, Genant HK, Davis JW, Miller PD & Wasnich RD. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporosis International 1993 3 120-126. (doi:10.1007/BF01623272)
36. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK & Thompson DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone 1999 25 613-619. (doi:10.1016/S8756-3282(99)00202-1)
37. Black DM, Arden NK, Palermo L, Pearson J & Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. Journal of Bone and Mineral Research 1999 14 821-828. (doi:10.1359/jbmr.1999.14.5.821)
38. Burger H, van Daele PL, Algra D, Hofman A, Grobbee DE, Schutte HE, Birkenhager JC & Pols HA. Vertebral deformities as predictors of non-vertebral fractures. BMJ 1994 309 991-992. (Pubitemid 24309479)
39. Giustina A, Mazziotti G & Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 2008 29 535-559. (doi:10.1210/er.2007-0036)